How many employees does Iovance Biotherapeutics, Inc. have?

Iovance Biotherapeutics, Inc. reported 975 employees for the fiscal year ending Dec 2025, in the annual report it filed on February 24, 2026. That is up 16.3% from a year earlier.

What is Iovance Biotherapeutics, Inc.'s revenue per employee?

Iovance Biotherapeutics, Inc. brought in $264M of revenue in fiscal Dec 2025, which is $270K per employee. That ranks 34 of 46 companies we track in Biotechnology, where the median is $574K.

Where do these numbers come from?

Employee counts and revenue are taken from each company's own annual report (Form 10-K). Open roles are counted from the company's public job board where we have matched one. Companies report headcount once a year, sometimes rounded, so small changes can be noise.

Company data

Iovance Biotherapeutics, Inc. employees and revenue per employee

IOVA · Biotechnology · $6.53B market cap

Iovance Biotherapeutics, Inc. had 975 employees at the end of fiscal Dec 2025, up 16.3% from a year earlier. Revenue for the year was $264M, up 60.6% from a year earlier, or $270K per employee. Revenue and headcount both grew, and revenue grew faster.

Employees

975

+16.3% YoY

Revenue

$264M

+60.6% YoY

Revenue / employee

$270K

Peer median $574K

Rank in industry

34 of 46

Biotechnology

Headcount against revenue

Both lines start at 100 in the first year we hold, so you can see which one grew faster.

EmployeesRevenueIndexed to 100 in Dec 2023

Hover a year for the numbers.

IOVA employees and revenue by fiscal year
Year ending	Employees	Revenue	Per employee	Staff YoY	Revenue YoY
Dec 2025	975	$264M	$270K	+16.3%	+60.6%
Dec 2024	838	$164M	$196K	+50.4%	+13699.0%
Dec 2023	557	$1.2M	$2K	—	—

Open roles: we have not matched a verified job board for this company yet.

Employees, last six fiscal years

Revenue per employee, last six fiscal years

Iovance Biotherapeutics, Inc. against similar companies

The closest industry peers by revenue, from Biotechnology.

Company	Employees	Revenue	Revenue / employee	Shape
LGND Ligand Pharmaceuticals Incorporated	47	$268M	$5.70M	Leaner
KRYS Krystal Biotech, Inc.	295	$389M	$1.32M	Efficient growth
TVTX Travere Therapeutics, Inc.	497	$491M	$987K	Efficient growth
BBIO BridgeBio Pharma, Inc.	834	$502M	$602K	Efficient growth
RYTM Rhythm Pharmaceuticals, Inc.	414	$190M	$458K	Hiring ahead
ADPT Adaptive Biotechnologies Corporation	624	$277M	$444K	Efficient growth
RCUS Arcus Biosciences, Inc.	601	$247M	$411K	Contracting
TWST Twist Bioscience Corporation	979	$377M	$385K	Efficient growth
IOVA Iovance Biotherapeutics, Inc.	975	$264M	$270K	Efficient growth

Every Healthcare company

Questions about Iovance Biotherapeutics, Inc.

How many employees does Iovance Biotherapeutics, Inc. have?: Iovance Biotherapeutics, Inc. reported 975 employees for the fiscal year ending Dec 2025, in the annual report it filed on February 24, 2026. That is up 16.3% from a year earlier.
What is Iovance Biotherapeutics, Inc.'s revenue per employee?: Iovance Biotherapeutics, Inc. brought in $264M of revenue in fiscal Dec 2025, which is $270K per employee. That ranks 34 of 46 companies we track in Biotechnology, where the median is $574K.
Where do these numbers come from?: Employee counts and revenue are taken from each company's own annual report (Form 10-K). Open roles are counted from the company's public job board where we have matched one. Companies report headcount once a year, sometimes rounded, so small changes can be noise.

Free game

Think you can pick better than the S&P 500?

Pick 15 stocks, lock them in, and we score them against the index every trading day for ten years. Free, with a public leaderboard.

Enter the challenge

More data

Compare IOVA with the rest of the market

See who earns the most per employee, who is hiring, and who is cutting, across every company we track.

Leaderboard Healthcare

Source: employee counts and revenue as stated in Iovance Biotherapeutics, Inc.'s annual reports (Form 10-K), latest filed February 24, 2026. This is data, not a recommendation to buy or sell IOVA.